menu close
www.vergegenomics.com

Verge Genomics Stock

Company Profile:

Verge Genomics operates as a drug discovery company that combines artificial intelligence and neuroscience expertise to find new drugs that would dramatically improve the lives of patients suffering from neurodegenerative disease.

Sign up for SecondMarket™ to view the market and buy or sell Verge Genomics Stock
Buy + Sell
Leverage Your Equity to Help Achieve More.

Verge Genomics Management Team

  • Chief Scientific Officer

    Rob Scannevin

  • Director

    Steve Kanes

  • Director

    Emily Melton

  • Chief Business Officer

    Jane Rhodes

  • Co-founder, CEO, Director

    Alice Zhang

  • Director

    Andrew Allen

Verge Genomics Major Investors

  • DFJ Venture

  • IA Ventures

  • WuXi AppTec

  • Great Oaks Venture Capital

  • Section 32

  • Tao Capital Partners

  • BlackRock Inc

  • Eli Lilly & Company

  • Slow Ventures

  • Vulcan Capital

  • Two Sigma Ventures

  • Merck Global Health Innovation Fund LLC

  • OS Fund

  • Threshold Ventures

  • LifeForce Capital

  • Karlin Ventures

  • Agent Capital

  • ALS Investment Fund

Learn More About Verge Genomics Stock

Buy Verge Genomics Stock
01

Verge Genomics stock does not trade on public stock exchanges. Verge Genomics stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Verge Genomics stock you can either buy shares directly through company or work with a secondary trading marketplace like Nasdaq Private Market.

Learn more about the secondary market for private company shares on the investors page.

Sell Verge Genomics Stock
02

Verge Genomics Stock does not trade on public stock exchanges. In order to sell Verge Genomics shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.

Learn more about NPM services for selling privately held stock on the Employee Shareholders page.

Read more about how to sell private company stock on the private secondary market:

Verge Genomics Stock Price
03

Verge Genomics does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the Tape D™ database from Nasdaq Private Market, you can view Verge Genomics share price and other valuable private market data.

Read more about secondary market private company stock prices:

Verge Genomics Stock Ticker Symbol
04

There is no ticker symbol for Verge Genomics stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.

Criteria to Sell Verge Genomics Stock
05

Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Verge Genomics stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.

Learn more about selling privately held stock on the Employee Shareholders page.

Read more about how to sell shares of a private company and eligibility for selling privately held stock:

Criteria to Buy or Invest in Verge Genomics Stock
06

Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Verge Genomics stock, you need to be an accredited entity or institutional investor.

Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.

Verge Genomics Stock Settlement
07

Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.

To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.

Verge Genomics IPO
08

Verge Genomics is a private company and has not had an IPO. There is currently no Verge Genomics IPO price. Get started to begin exploring the Nasdaq Private Market Tape D™ database and gain access to actionable data related to Verge Genomics IPO.

Learn more about Tape D™ private company stock data for institutional investors on the on the Tape D™ Product Page.

Sign up for SecondMarket™ to view the market and buy or sell Verge Genomics Stock
Buy + Sell

*All trademarks are the property of their respective owner(s). Unless expressly stated otherwise, companies listed on this site are not sponsoring, endorsing, or otherwise affiliated with, Nasdaq Private Market, LLC, and none of the statements on this website should be attributed to a listed company.

Other Companies

Roman Health Ventures-Logo

Ro

Healthcare technology for a patient-centric healthcare system.

Insitro-Logo

insitro

Drug discovery and development company.

Eikon Therapeutics Inc-Logo

Eikon Therapeutics

A new biopharmaceutical company using revolutionary technology to discover novel treatments for life-threatening diseases.

Indigoag-Logo

Indigo Agriculture

Improves grower profitability, environmental sustainability, and consumer health through the use of natural microbiology and digital technologies.

Weareresilience-Logo

Resilience

Operates as technology-focused biomanufacturing company dedicated to broadening access to complex medicines.

Virta Health-Logo

Virta Health

Online specialty medical clinic focused on reversing type 2 diabetes.

Adimab

Operates as an antibody discovery company.

Cambrian Bio

Clinical-stage drug development company.

TurtleTree

Biotech company focused on creating sustainable and innovative nutrition solutions.

Source: Nasdaq Private Market Tape D™